Everything you need to know about [typedjs]news, publications, and courses[/typedjs]
Curso de Derecho Farmacéutico
La Fundación CEFI celebra su Curso de Derecho Farmacéutico los próximos días 22 y 23 de octubre.Este año además coincide su 20ª edición.Abriremos las inscripciones
✍️ 𝗥𝗲𝘃𝗶𝘀𝘁𝗮 𝗖𝘂𝗮𝗱𝗲𝗿𝗻𝗼𝘀 𝗱𝗲 𝗗𝗲𝗿𝗲𝗰𝗵𝗼 𝗙𝗮𝗿𝗺𝗮𝗰𝗲́𝘂𝘁𝗶𝗰𝗼 𝗡 𝟵𝟯
No os perdáis los interesantes artículos de este número de la revista que abordan aspectos de máxima relevancia y actualidad del medicamento. ▶︎ https://cefi.es/tienda/publicaciones/revista-cuadernos/revista-cuadernos-no-93-abril-junio-2025/ 👇
Ya disponible el Nº 104 de la revista Comunicaciones
Ya podéis acceder a los interesantes contenidos del número 104 de la revista Comunicaciones.En este primer número de la revista COMUNICACIONES de este año tenemos
💊 𝗨𝗣𝗗𝗔𝗧𝗘 𝗠𝗘𝗗𝗜𝗖𝗔𝗠𝗘𝗡𝗧𝗢
El próximo 𝟮𝟮 𝗱𝗲 𝗺𝗮𝘆𝗼 𝗱𝗲 𝟭𝟬:𝟬𝟬-𝟭𝟮:𝟬𝟬𝗵. celebraremos un 𝗦𝗲𝗺𝗶𝗻𝗮𝗿𝗶𝗼 𝗼𝗻𝗹𝗶𝗻𝗲 que pretende ser una 𝗮𝗰𝘁𝘂𝗮𝗹𝗶𝘇𝗮𝗰𝗶𝗼́𝗻 𝗱𝗲 𝗹𝗮 𝗻𝗼𝗿𝗺𝗮𝘁𝗶𝘃𝗮 𝗱𝗲𝗹 𝗺𝗲𝗱𝗶𝗰𝗮𝗺𝗲𝗻𝘁𝗼 actualmente en proceso de
Ya disponible el Nº 92 de nuestra revista Cuadernos
Revista Cuadernos nº 92 con contenidos de gran actualidad para el sector farmacéutico, disponible para compra y descarga. ¡No os perdáis los contenidos de la
Save the Date Curso Derecho Farmacéutico CEFI
La Fundación CEFI celebra su Curso de Derecho Farmacéutico los próximos días 22 y 23 de octubre. Este año además coincide con la 20ª edición y nos gustaría
11 años de transparencia en España e impacto en el medicamento. Qué se ha hecho bien y qué debe cambiar
Podéis descargar el número monográfico de nuestra revista Cuadernos de Derecho Farmacéutico en este enlace: ▶︎ https://cefi.es/transparencia Es el resultado de seis años de trabajo
Ya disponible el Nº 103 de la revista Comunicaciones
Ya podéis acceder a los interesantes contenidos del número 103 de la revista Comunicaciones. Gracias a los colaboradores por sus magníficas aportaciones. This post is
Ya disponible el Nº 91 de nuestra revista Cuadernos
Revista Cuadernos nº 91 con contenidos de gran actualidad para el sector farmacéutico, disponible para compra y descarga. ¡No os perdáis los contenidos de la
Ya disponible el Nº 90 de nuestra revista Cuadernos
Revista Cuadernos nº 90 con contenidos de gran actualidad para el sector farmacéutico, disponible para compra y descarga. ¡No os perdáis los contenidos de la
Nº 102 de la revista Comunicaciones
Ya podéis acceder a los interesantes contenidos del número 102 de la revista Comunicaciones. Gracias a los colaboradores por sus magníficas aportaciones. This post is
Issue 89 of the Cuadernos de Derecho Farmacéutico (Pharmaceutical Law Review) journal
Don’t miss out on this issue of Cuadernos de Derecho Farmacéutico, which examines the following: The current regulatory framework for advertising medical products, the changes
Pharmaceutical Law Course videos
We are pleased to share videos of each of the round tables at the 19th edition of the Pharmaceutical Law Course, held on 5 and
INCENTIVES FOR HEALTH INNOVATION AS A COMPETITIVE ADVANTAGE FOR THE EU
INCENTIVES FOR HEALTH INNOVATION AS A COMPETITIVE ADVANTAGE FOR THE EU We would like to count on your participation in the debate on INCENTIVES FOR HEALTH
Nº 101 de la revista Comunicaciones
Ya podéis accedes a los interesantes contenidos del número 101 de la revista Comunicaciones. Gracias a los colaboradores por sus magníficas aportaciones. This post is
LOS INCENTIVOS A LA INNOVACIÓN EN SALUD COMO VENTAJA COMPETITIVA DE LA UE
Nos gustaría contar contigo para participar en el debate sobre LOS INCENTIVOS A LA INNOVACIÓN EN SALUD COMO VENTAJA COMPETITIVA DE LA UE, que tendrá lugar el
WORLD INTELLECTUAL PROPERTY DAY. THE IMPORTANCE OF INNOVATION. THE IMPORTANCE OF PROTECTING IT
To mark World Intellectual Property Day 2024, we would like to highlight the fundamental role of intellectual property in stimulating innovation and creativity. We share
Issue 88 of Cuadernos de Derecho Farmacéutico [Pharmaceutical Law Review]
Interesting content in the journal Cuadernos de Derecho Farmacéutico. Publication of a new version of the Government of Catalonia’s Guide on the advertising of medicinal
100TH ISSUE OF THE JOURNAL COMUNICACIONES
This morning we held an event to commemorate the 100th issue of the journal Comunicaciones en Propiedad Industrial y Derecho de la Competencia (Communications on
Issue 87 of our journal Cuadernos now available
Issue 87 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
PHARMACEUTICAL LAW COURSE
This week, the registration period opened for the Pharmaceutical Law Course, which is set to feature highly topical subjects and excellent speakers. Don’t miss this
PATENTS AND BIOTECHNOLOGY IN THE HEALTH SECTOR. UNIVERSITY OF ALICANTE SEMINAR
The Department of Commercial Law and Procedural Law at the University of Alicante’s Law Faculty is organising an interesting seminar on patent law and biotechnology
Issue 86 of our journal Cuadernos now available
Issue 86 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
Issue 99 of our journal Comunicaciones now available
Issue 99 of the journal Comunicaciones, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
Issue 85 of our journal Cuadernos now available
Issue 85 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
Issue 98 of our journal Comunicaciones now available
Issue 98 of the journal Comunicaciones, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
World Intellectual Property Day 2023. Women and IP: Accelerating Innovation and Creativity
World Intellectual Property Day 2023. Women and IP: Accelerating Innovation and Creativity 26 April is World Intellectual Property Day. This year WIPO’s theme is Women
New Design for the journal Cuadernos de Derecho Farmacéutico (Pharmaceutical Law Review)
The CEFI Foundation has just celebrated its 40th anniversary. During these years, it has grown considerably, as has our network of collaborators when it comes
Issue 84 of our journal Cuadernos now available
You can now access issue 84 of the journal Cuadernos de Derecho Farmacéutico (Pharmaceutical Law Review) on our website: https://cefi.es/tienda/publicaciones/revista-cuadernos/revista-cuadernos-no-84-enero-marzo-2023 Remember that you can also arrange
INTERNATIONAL WOMEN’S DAY
Congratulations to the women who break social and economic barriers every day to achieve a more egalitarian society. And especially to the women linked to
Proposals for innovation in accessing innovative medicinal products in the Spanish NHS
This week we presented the report ‘Proposals for innovation in accessing innovative medicinal products in the Spanish NHS’. This report is part of CEFI’s Access
Issue 97 of our journal Comunicaciones now available
Issue 97 of the journal Comunicaciones, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
Issue 83 of our journal Cuadernos now available
You can now access issue 83 of the journal Cuadernos de Derecho Farmacéutico (Pharmaceutical Law Review) on our website: https://cefi.es/tienda/publicaciones/revista-cuadernos/revista-cuadernos-no-83-octubre-diciembre-2022/ Remember that you can also arrange
Issue 82 of our journal Cuadernos now available
Issue 82 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
PHARMACEUTICAL LAW COURSE
BIOMEDICINE, MEDICINES AND PUBLIC HEALTH This post is also available in: Spanish
Issue 96 of our journal Comunicaciones now available
Issue 96 of the journal Comunicaciones, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
PHARMACEUTICAL LAW COURSE 2022
Save the dates! This year’s Pharmaceutical Law Course will be held on 27 and 28 September, with a prior online session on 26 September from
BIOMEDICINE. MEDICINAL PRODUCTS AND PUBLIC HEALTH. THE CEFI FOUNDATION’S PHARMACEUTICAL LAW COURSE
We are currently preparing the contents for the next Pharmaceutical Law Course, which will take place at the end of September. We will review the
Limiting patent rights for COVID vaccines
This is bad news for the biomedical innovation sector and in terms of having a robust intellectual property system. We express our disagreement with the
Issue 81 of our journal Cuadernos now available
Issue 81 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
CEFI FOUNDATION TESTIMONIES
We would like to share this video we have made to mark our 40th Anniversary. It includes testimonies from CEFI’s friends and patrons on three
40th Anniversary of CEFI
Fantástico ambiente de colaboración entre instituciones, colaboradores, patronos y amigos de CEFI. On 25 May we celebrated our 40th Anniversary in an event in the
CEFI 40th Anniversary Celebration
CEFI 40th Anniversary Celebration Last night CEFI celebrated its 40th anniversary at an event in the gardens of the Lázaro Galdiano Museum. The CEFI Foundation
Special issue of our Cuadernos journal now available
Introduction The CEFI Foundation is celebrating its 40th anniversary (1982-2022) while we are still struggling to overcome the COVID-19 pandemic. The pandemic has reminded us
Issue 95 of our journal Comunicaciones now available
Issue 95 of the journal Comunicaciones, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
Marta Grande de Domingo. Takeda Farmacéutica España S.A
Summary of the research/innovation: In the clinical field today, we need to know how different patients with multiple myeloma respond to treatment prescribed in
Iris Simón Sáez GENyO-Pfizer Centre
Summary of the research/invention I work on prostate cancer research. Prostate cancer patients are often treated with androgen deprivation hormone therapies, but most eventually develop
Santiago Cañellas Román Janssen-Cilag Research Centre (Centro de Investigación Janssen-Cilag) Toledo
Summary of the research/invention: The research team patented a series of potent inhibitors of NLRP3 inflammasome formation, the dysregulation of which is associated with several
World Intellectual Property Day 2022 IP and Youth: Innovating for a Better Future
Today, 26 April, is World Intellectual Property Day. This year is dedicated to intellectual property and youth: innovating for a better future. At CEFI we
Issue 80 of our journal Cuadernos now available
Issue 80 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. This post is also available
CEFI, 40 years working in defence of innovation and intellectual property
We at the CEFI Foundation are very proud to celebrate our 40th Anniversary this year. CEFI has been working in defence of innovation and intellectual
Issues 79 and 94 of our journals now available
Issue 79 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue
ADVERTISING MEDICINAL PRODUCTS IN THE INTERIM PERIOD BETWEEN MARKETING AUTHORISATION AND THE DECISION ON PRICING AND PUBLIC FUNDING
This paper analyses the promotion of medicines for human use that have already received marketing authorization, when the advertising is made before the resolution on
STRONG INTEREST IN OUR DISCUSSION ON OBSERVATIONAL STUDIES ON MEDICATIONS AND PATIENT SUPPORT PROGRAMMES
On 15 October we had an interesting discussion on Observational Studies on Medications and patient support programmes in the new regulations that aroused a lot
PHARMACEUTICAL LAW PUBLICATION nº 78 Available for purchase and download
The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health
Advertising of medicinal products before a financing decision by the National Health System
Superior Court of Justice of the Basque Country, Judicial Review Chamber, Judgment 246/2021 of 30 June resolved positively on a question widely debated in the
Observational studies of medicinal products and patient support programmes in the new regulation
CEFI is organising a seminar on observational studies of medicinal products and patient support programmes, which is set to take place on 15 October. As
nº93 COMMUNICATIONS ON INDUSTRIAL PROPERTY AND COMPETITION LAW
Available for download. The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in
The National Court of Spain (Audiencia Nacional) paves the way for a final confirmation of the legality of free price policies
In a recent ruling dated 22 April 2021, the National Court has upheld the Spanish National Markets and Competition Commission (CNMC) decision of 19 January
PHARMACEUTICAL LAW PUBLICATION nº 77
Considerations on the pricing system for medicinal products. Lourdes Fraguas Gadea Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision.
Council conclusions on intellectual property policy
It takes as its starting point, inter alia, the current situation as regards identifying intellectual property as a key asset for the EU, as a
PHARMACEUTICAL LAW COURSE -25TH ANIVERSARY- CLOSING SESSION
Rosa Romero Sánchez, Presidenta de la Comisión de Sanidad del Congreso de los Diputados and Katia Piñol, Presidenta de CEFI highlight the importance of holding
BIOMEDICINE AND COMPETITION LAW
We cant think in a best way to end our 25th Pharmaceutical Law Course Aniversary . Moisés Ramírez, Patrono de CEFI together with Sergio Sinovas,
DIGITAL, PROMOTION AND COMPLIANCE IN PHARMACEUTICAL SECTOR
In this panel we are going to talk about promotion, digital aspects and compliance. As Speakers: Silvia Martínez, Patrono de CEFI, Jose Zamarriego Izquierdo, Director
PUBLIC PROCUREMENT OF MEDICINES
Alberto Dorrego. Abogado socio de Eversheds Sutherland claim for a specific regulación on public procurement for innovative medicines and vaccines. He also highlight the importance
PRICE, FINANCING DECISION AND PATIENT ACCESS TO INNOVATIVE MEDICINES
Second week of the Pharmaceutical Law Course begin with one of the main issues for innovative medicines. Lead by Javier de Urquía Martí, member of
Promotion of Research through IP protection
Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela
DEBATE ON ADVANCED THERAPIES AND BIOLOGICAL MEDICINAL PRODUCTS
Jorge Muñoz, Member of CEFI Board lead the debate on advanced therapies an biological medicinal products. Sol Ruíz, Jefe de División de Productos Biológicos, Terapias
Clinical Research and data protection debate
Interesting debate with Jesús Rubí, Adjunto a la Dirección de la Agencia Española de Protección de Datos, Amelia Martín Uranga, Responsable de la Plataforma de Medicamentos
Fantastic first session
With Javier Castrodeza, Ex Secretario General de Sanidad y Catedrático de Medicina Preventiva y Salud Pública, Lourdes Fraguas, Abogada of Cousel Herbert Smith Freehills Spain,
CEFI Pharmaceutical Law Course starts
Katia Piñol Torres, our President and Patricia Lacruz. Directora General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia del Ministerio de
Observational studies and patient support programmes: comments on Royal Decree 957/2020
Royal Decree 957/2020 As of 2 January 2021, observational studies of medicinal products for human use (‘OSM’) are to be regulated in Spain by Royal
COMMUNICATIONS ON INDUSTRIAL PROPERTY AND COMPETITION LAW nº 92 Available for download and purchase.
Section One. Current Affairs Medicine in the courts in 2020. Jordi Faus, Xavier Moliner, Eduard Rodellar, Santiago Tomás, Anna Gerbolés, Lluís Alcover, Laura Marquès, Juan
Why would compulsory licensing of vaccines and COVID-19 treatments not lead to better access to innovation and benefits for patients?
There is an ongoing debate about certain national and international policy initiatives concerning the mandatory licensing of COVID-19 vaccine patents and we see the need
The new 2021 FARMAINDUSTRIA code
As we all know, on 1 January 2021 the new version of the Code of Practice for the Pharmaceutical Industry (the ‘new Code’ or, simply,
WORLD INTELLECTUAL PROPERTY DAY– 26 APRIL
In light of the current COVID-19 health crisis, it is an apt moment to highlight the importance of intellectual property. Intellectual and industrial property, among
Issue 76 of the journal Cuadernos DF (Pharmaceutical Law Review) now available
Interruption of supply or the withdrawal of medicines from the market and competition rules. Henar González Durántez y Pilar Carrasco del Olmo 2021 versión
The withdrawal or interruption of medicine supply from a competition law perspective
Recent investigations of the pharmaceutical sector by the competition authorities demonstrate a focus on examining a number of actions that could entail an interruption of
Vaccines in times of pandemic
On 19 January CEFI organised a seminar to deepen our understanding of vaccines in times of pandemic. Interest in the debate, reflected in the number
Vaccine debate at CEFI
Fascinating debate on vaccines with 266 registered participants and fantastic presentations by the speakers. This post is also available in: Spanish
Final days for registration: Online conference ‘Deepening our understanding of vaccines in times of pandemic’
On 19 January 2021, CEFI will hold the online conference entitled Deepening our understanding of vaccines in times of pandemic. Registration is free of charge.
Two new issues of CEFI’s journal published
Two new issues of the journal published by CEFI are available: Cuadernos de Derecho Farmacéutico issue 75 (October-December 2020). Comunicaciones en Propiedad Industrial y Derecho
CEFI contributes to the debate on vaccines in times of pandemic
On 19 January 2021, CEFI will hold an online conference entitled Deepening our understanding of vaccines in times of pandemic. Programme and registration This post
Eventful days of regulation and legislation in the world of pharma and innovation
There have been some eventful days recently in terms of important pharmaceutical regulations and legislation: Community pharma strategy to which we dedicated a post on
Global regulatory alignment on COVID-19 medicines and vaccines
Global action in the fight against the COVID-19 pandemic. Joint statement by the International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization
Expert analysis on data protection
In the next issue of the Comunicaciones journal, CEFI is pleased to count on the expert opinion of Jesús Rubí Navarrete, Deputy Director of the
Improving access to therapeutic innovation
Natividad Calvente Cestafe, Director of Innovation, Training and Institutional Relations at the General Council of Pharmaceutical Associations contributes to a monographic issue of the journal
The two-part test for grant of supplementary protection certificates is here to stay, but at what price?
Commentary on the Royalty Pharma Ruling of the CJEU of 30 April 2020. Full text: Comunicaciones ENG oct 2020 pag This post is
CEFI Foundation submits its claims to the Draft Reference Price Order 2020
The reference price system and annual reference price orders are intended to contribute to the sustainability of the SNS. They should also promote the right
La Fundación CEFI presenta sus alegaciones al Proyecto de Orden de precios de referencia 2020
El sistema de precios de referencia y las sucesivas ordenes anuales de precios de referencia pretenden contribuir a la sostenibilidad del SNS. También deben fomentar
New issue of the journal Cuadernos de Derecho Farmacéutico (Pharmaceutical Law Review)
Issue 74 (July-September 2020) of the journal Cuadernos de Derecho Farmacéutico is available online. Monographic issue ‘Spanish National Health System changes for innovation, efficiency and
Draft Order updating the Price Reference System in 2020
The Ministry of Health has published Draft Order SND/ /2020, of, by which the price reference system for medicinal products in the Spanish National Health
Spanish National Health System changes for innovation, efficiency and patient service
Amidst the current health, social and economic crisis caused by the Covid-19 pandemic and in a context conducive to reflection and debate with the creation
‘Next Generation EU’, the European Recovery Programme
The European Council has reached a historic agreement on a EUR 750 billion package for rebuilding the European economy following the COVID-19 pandemic: EUR 390
Nuevo número de la revista Cuadernos de Derecho Farmacéutico
Disponible en la web el número 73 (abril-junio 2020) de la revista Cuadernos de Derecho Farmacéutico. Sumario: La protección judicial de los datos de registro
Muestras gratuitas de medicamentos. El TJUE restringe las condiciones de distribución
Una reciente sentencia del TJUE (asunto C‑786/18), pronunciándose sobre las cuestiones prejudiciales planteadas por el Tribunal Supremo alemán y tras estudiar el alcance del artículo
Régimen económico de los medicamentos huérfanos.Exonerados del sistema de precios de referencia
El BOE de hoy, viernes 12 de junio, publica la Resolución de 2 de junio de 2020, de la Dirección General de Cartera Común de
Guía de la CNMC sobre programas de cumplimento normativo en relación con las normas de defensa de la competencia
La CNMC ha publicado esta Guía que: Fue sometida a consulta pública en febrero de 2020 y recoge las aportaciones realizadas. Contiene los criterios que
Cuadernos de Derecho Farmacéutico
Cuadernos de Derecho Farmacéutico no. 72 (enero-marzo 2020) publicado y disponible en la web Índice: El precio de los medicamentos: transparencia versus confidencialidad. Francisco Valero
This post is also available in: Spanish
